A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer’s Disease, the 5XFAD Mouse
Authors:
- Antonio J. López-GamberoAntonio J. López-Gambero
- Cristina Rosell-ValleCRCristina Rosell-Valle
- Dina Medina-VeraDina Medina-Vera
- Juan Antonio NavarroJNJuan Antonio Navarro
- Antonio VargasAVAntonio Vargas
- Patricia RiveraPRPatricia Rivera
- Carlos SanjuanCSCarlos Sanjuan
- Fernando Rodríguez de FonsecaFFFernando Rodríguez de Fonseca
- Juan SuárezJuan Suárez
Open Access
- 20 May 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (10) , 5365
Abstract
Increasing evidence links metabolic disorders with neurodegenerative processes including Alzheimer’s disease (AD). Late AD is associated with amyloid (Aβ) plaque accumulation, neuroinflammation, and central insulin resistance. Here, a humanized AD model, the 5xFAD mouse model, was used to further explore food intake, energy expenditure, neuroinflammation, and neuroendocrine signaling in the hypothalamus. Experiments were performed on 6-month-old male and female full transgenic (Tg5xFAD/5xFAD), heterozygous (Tg5xFAD/-), and non-transgenic (Non-Tg) littermates. Although histological analysis showed absence of Aβ plaques in the hypothalamus of 5xFAD mice, this brain region displayed increased protein levels of GFAP and IBA1 in both Tg5xFAD/- and Tg5xFAD/5xFAD mice and increased expression of IL-1β in Tg5xFAD/5xFAD mice, suggesting neuroinflammation. This condition was accompanied by decreased body weight, food intake, and energy expenditure in both Tg5xFAD/- and Tg5xFAD/5xFAD mice. Negative energy balance was associated with altered circulating levels of insulin, GLP-1, GIP, ghrelin, and resistin; decreased insulin and leptin hypothalamic signaling; dysregulation in main metabolic sensors (phosphorylated IRS1, STAT5, AMPK, mTOR, ERK2); and neuropeptides controlling energy balance (NPY, AgRP, orexin, MCH). These results suggest that glial activation and metabolic dysfunctions in the hypothalamus of a mouse model of AD likely result in negative energy balance, which may contribute to AD pathogenesis development.Keywords
Funding Information
- H2020 European Research Council (EULACH16/T010131)
- Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (RTC-2016-4983-1)
- Instituto de Salud Carlos III (PI19/01577, PI19/00343, CPII17/00024, CP19/00068, FI20/00227, IFI18/00042)
- Ministerio de Sanidad, Consumo y Bienestar Social (PNSD 2019/040, PNSD 2020/048)
- Consejería de Transformación Económica, Industria, Conocimiento y Universidades. Junta de Andalucía (P18-TP-5194)
This publication has 112 references indexed in Scilit:
- Complementary Roles of Orexin and Melanin-Concentrating Hormone in Feeding BehaviorInternational Journal of Endocrinology, 2013
- GLP ‐1 receptor activated insulin secretion from pancreatic β‐cells: mechanism and glucose dependenceDiabetes, Obesity and Metabolism, 2012
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive declineJournal of Clinical Investigation, 2012
- Obesity is associated with hypothalamic injury in rodents and humansJournal of Clinical Investigation, 2012
- Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's diseaseNeurobiology of Aging, 2011
- Biliverdin reductase-A protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairmentBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- AMP-activated protein kinase (AMPK) activity is not required for neuronal development but regulates axogenesis during metabolic stressProceedings of the National Academy of Sciences, 2011
- Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer’s disease transgenic miceJournal of Neurochemistry, 2010
- Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascadeProceedings of the National Academy of Sciences, 2008
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991